Notices
19 July 2017
Issue Information
19 July 2017
Table of contents
19 July 2017
Direct‐acting antivirals and recurrence of hepatocellular carcinoma
Jorge A. Marrero, Amit G. Singal – 19 July 2017
Hepatology Highlights – August 2017
Yecheskel Schneider, Robert S. Brown, Monica Saumoy, Robert E. Schwartz, Vikas Gupta, Russell Rosenblatt – 19 July 2017
Heparan sulfate promotes recovery from acute liver injury: Inhibition of progressive cell death or enhanced regeneration?
Udayan Apte, Neil Kaplowitz – 18 July 2017
An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice
Ying Fu, Shana Silverstein, Justine N. McCutcheon, Marcin Dyba, Raghu G. Nath, Monika Aggarwal, Heidi Coia, Angela Bai, Jishen Pan, Jiji Jiang, Bhaskar Kallakury, Hongkun Wang, Yu‐Wen Zhang, Giuseppe Giaccone, Aiwu Ruth He, Fung‐Lung Chung – 18 July 2017 – Hepatocellular carcinoma (HCC) is the third leading cause of cancer–related deaths worldwide, mainly because of its poor prognosis. A valid mechanism‐based prognostic biomarker is urgently needed. γ‐hydroxy‐1,N2‐propanodeoxyguanosine (γ‐OHPdG) is an endogenously formed mutagenic DNA adduct derived from lipid peroxidation.
Critical elements in pediatric allograft selection
George V. Mazariegos – 18 July 2017
Heparan sulfate promotes recovery from acute liver injury: Inhibition of progressive cell death or enhanced regeneration?
Udayan Apte, Neil Kaplowitz – 18 July 2017